Cardinal Health, Inc. (CAH) - Stock Analysis

Last updated: Sep 19, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Cardinal raised FY2027 adjusted EPS guidance after strong fiscal Q1 earnings growth; shares gained 15.5% through November 10 and reached a new 12-month high.

Loading chart data...

Idea window: 11/11/2026 – 11/18/2026Sector: Healthcare

AI Analyst Overview

Last Price
$272.34
Market Cap
$62.95B
1D Return
-2.15%
YTD Return
+33.78%

Loading chart data...

Valuation Metrics

P/E
35.1
P/B
-20.9
P/S
0.2
EV/EBITDA
20.1
Div Yield
0.75%

Fundamental Analysis

5.0

Key Financial Insights: • Strong cash flow • Thin profitability • Weak liquidity CAH delivers strong cash flow and manageable leverage, but thin margins, negative equity, and weak liquidity warrant caution despite a low sales multiple.

CashFlow
BalanceSheetRisk

Price Behavior

4.0

Key Price Behavior Insights: • Downtrend intact • Support test • Rebound threshold Support Level: $225–226 Resistance Level: $232–235 CAH is in a bearish last-month downtrend, with $225–226 support at risk; reclaiming $232–235 would signal easing pressure.

Bearish
Support

Sentiment & News

7.0

Key News Insights: • Growth Momentum • Institutional Buying • Margin Risks Cardinal Health's growth drivers and institutional backing support a constructive outlook, though pricing, cost, and capital-spending risks warrant monitoring amid recent share weakness.

CardinalHealth
Healthcare
AI

AI Summary

6.0
Neutral

CAH is now a cash-generative healthcare-services and specialty-growth story rather than a pure distributor, but at ~33x earnings investors should require proof that post-refund, post-tax-item operating growth and free cash flow remain strong as Specialty normalizes and acquisitions integrate.

SpecialtyGrowth
ValuationRisk
CashFlow
AI summary updated 62 days ago

Description

Cardinal Health, Inc. is a global healthcare services and products company that supplies hospitals, pharmacies, clinics, laboratories and patients at home. It operates two reporting segments: Pharmaceutical distribution and services for branded, generic and specialty drugs, and Medical, which manufactures and distributes a broad range of medical, surgical and laboratory supplies while providing supply-chain and kit assembly services to care providers. The company was founded in 1979 and is headquartered in Dublin, Ohio.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Nov 11Nov 18CAHCardinal Health, Inc.
Cardinal raised FY2027 adjusted EPS guidance after strong fiscal Q1 earnings growth; shares gained 15.5% through November 10 and reached a new 12-month high.
Closed+0.3%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.